Pre-hospital Antifibrinolytics for Traumatic Coagulopathy and Haemorrhage (The PATCH Study) [ 2013 - 2018 ]

Research Grant

Researchers: Prof Russell Gruen (Principal investigator) ,  Prof Stephen Bernard (Principal investigator) ,  A/Pr Huyen Tran ,  Dr Dashiell Gantner ,  Prof Biswadev Mitra
View all 8 related researchers

Brief description About 2500 Australians die annually from severe injuries. Bleeding is exacerbated by early-onset clotting defects, which are associated with high mortality. The antifibrinolytic agent tranexamic acid has been shown to reduce mortality due to bleeding when given in hospital in less developed trauma systems, but its usefulness as a pre-emptive strike at the scene of injury in developed systems is unknown. Building on our prehospital clinical trials expertise, we will conduct a trial to assess its effect on 6-month death and disability.

Funding Amount $AUD 1,739,170.39

Funding Scheme Project Grants

Notes Standard Project Grant